Attention Deficit Hyperactivity Disorder (ADHD) Practice Test 2025 - Free ADHD Practice Questions and Study Guide

Atomoxetine is recognized as a non-stimulant medication specifically approved for the treatment of ADHD. Unlike stimulant medications, which primarily target dopamine and norepinephrine in the brain, atomoxetine functions as a selective norepinephrine reuptake inhibitor (NRI). This class of medication can be particularly beneficial for individuals who may experience adverse effects from stimulants or those who prefer a non-stimulant option.

Atomoxetine's mechanism helps to improve attention and reduce impulsivity and hyperactivity without the immediate effects associated with stimulant medications. It is often chosen for individuals with ADHD who also have coexisting conditions, such as anxiety disorders, where stimulants might exacerbate symptoms.

In contrast, the other mentioned medications—methylphenidate and lisdexamfetamine—are both stimulant medications, and while they are effective for many patients, they work through different pathways than non-stimulants like atomoxetine. Amoxetine, on the other hand, is not recognized as a standard treatment for ADHD.